ARK Genomic Revolution ETF (ARKG)

58.40
Delayed Data
As of Dec 03
 -2.98 / -4.86%
Today’s Change
57.66
Today|||52-Week Range
115.15
-37.38%
Year-to-Date

Investment Objective

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

3 Stocks Cathie Wood Is Selling That Are Still Great Picks to Buy and Hold
Dec 02 / MotleyFool.com - Paid Partner Content
Has Cathie Wood Lost Her Touch?
Nov 24 / MotleyFool.com - Paid Partner Content

Performance

1 month-25.43% 3 years+26.50%
3 months-33.02% 5 years+29.03%
1 year-31.48% Since inception+17.50%
Data through 12/04/2021

Quote Details

Previous close$61.38
Open day’s range57.66 – 61.79
Net asset value (NAV)58.44 (12/03/2021)
Daily volume6,659,826
Average volume (3 months)2,388,719
Data as of 4:09pm ET, 12/03/2021

Peer Comparisonvs. Health ETFs

 ARKGCategory
Performance 5-yr return+29.03%+13.75%
Expense Gross exp ratio0.75%1.00%
Risk 5 year sharpe ratio0.920.91
Net assets$5.5B$2.4B
Average market cap$5.8B$37.7B
Average P/E--25.0
Dividend / Share--0.28%

Competitors

RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
TDOC Teladoc Health Inc7.60%
EXAS Exact Sciences Corp6.89%
PACB Pacific Biosciences of California Inc5.69%
FATE Fate Therapeutics Inc4.33%
IONS Ionis Pharmaceuticals Inc3.71%
VRTX Vertex Pharmaceuticals Inc3.70%
TWST Twist Bioscience Corp3.56%
NTLA Intellia Therapeutics Inc3.43%
BEAM Beam Therapeutics Inc3.15%
DNA Ginkgo Bioworks Holdings Inc3.08%